Methods of evaluating the extent of peritoneal carcinomatosis, or spread of cancerous tumors into the abdomen, are sometimes used to help determine treatment and prognosis for peritoneal cancers. Below are some of the scoring methods used to evaluate peritoneal cancer and to help determine treatment regimens and prognosis. This is not a complete list. Others not included here are the Gilly Peritoneal Carcinomatosis Staging method and the Simplified Peritoneal Cancer Index.
Peritoneal Cancer Index (PCI): A scoring system signifying the extent of metastasis into the peritoneal cavity. The abdomen and pelvis are divided into 13 identified regions. For each region, a Lesion Size (LS) score is calculated for the largest tumor in that region (not the number of tumors in the area, just the size of the largest tumor in that particular region).
The lesion size scores for each of the thirteen regions are added together. The highest score possible is 39 (13 times 3). Lower PCI scores are generally associated with a better prognosis and a greater likelihood of successful cytoreduction (debulking) surgery . PCI scores can be calculated before cytoreduction (debulking) surgery and after. It is possible for a PCI of 39 prior to cytoreduction surgery to become a PCI of 0 after surgery if all tumors are removed. It is also possible to have a low PCI score but a prognosis that is not as good if tumors are located in areas not accessible to surgical removal.
Completeness of Cytoreduction (CC) Score: Cytoreduction surgery attempts to remove all tumors in the peritoneal cavity (peritoneal surface malignancies/peritoneal carcinomatosis). It is not always possible to remove all tumors. The success of this surgery is scored as follows-
cytoreduction provides the best chance at long term survival. For
minimally invasive and low grade mucinous tumors that are more easily penetrated
by intraperitoneal chemotherapy, CC-0 and CC-1 cytoreduction scores are
considered "complete" cytoreduction. For intermediate and high grade
tumors, only a score of CC-0 is considered a complete cytoreduction.
Post-operative cytoreduction surgery scores of CC-2 and CC-3 are not usually
associated with long-term survival.
Prior Surgical Score: Definitive treatment for peritoneal carcinomatosis using debulking surgery and intraperitoneal chemotherapy is best when it is the initial treatment for this cancer. In some cases, a patient has had surgery without intraperitoneal chemotherapy for peritoneal metastasis prior to cytoreduction (debulking) surgery and intraperitoneal chemotherapy. The prior surgical score (PSS) gives a number value to surgeries done prior to the attempt at debulking/peritoneal chemotherapy treatment. As in the Peritoneal Cancer Index, the abdomen is divided into regions, in this case 9 regions.
Because scar tissue can trap cancer cells from previous surgeries, and because prior surgery may have caused raw sites to be open for deeper invasion of cancer cells that are more difficult to remove at later surgeries, a Prior Surgical Score of 3 (PSS-3) prior to cytoreduction (debulking) surgery and intraperitoneal chemotherapy is associated with reduced survival.
TNM Staging: TNM staging is also used in colorectal cancers. This staging system refers to the status of the tumor (T), lymph nodes (N) and metastasis of the cancer (M). For an explanation of this staging method and others , see American Cancer Society, Inc.-Staging of Colon and Rectal Cancers
Lymph Node Metastasis in Epithelial Malignancies of the Appendix With Peritoneal Dissemination Does Not Reduce Survival in Patients Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
This website is for informational and educational purposes only. Readers are encouraged to confirm the information contained herein with other sources. The information on this website is not complete and not intended to replace medical advice offered by physicians or health care providers. Patients and consumers should review the information carefully with their professional health care provider.
Copyright © 2005- 2010 C. Langlie-Lesnik RN BSN All rights Reserved
Last Updated 02/09/2010 11:26:03 AM